Lessons learned from COVID-19 to overcome challenges in conducting outpatient clinical trials to find safe and effective therapeutics for the next infectious pandemic
Related Posts
Uslan DZ, Kaur I, Garner OB, Yang S. Incorporating microbial cell-free DNA testing into healthcare-associated invasive fungal infection surveillance: benefits and challenges. Infect Control Hosp[...]
Diggs MR, Umbleja T, McCallum S, Zanni MV, Chu SM, Fitch KV, Bloomfield GS, Currier JS, Martinez E, Castle PE, Awwad A, Jain MK, Bedimo[...]
Yang OO. The immunopathogenesis of SARS-CoV-2 infection: Overview of lessons learned in the first 5 years. J Immunol. 2025 Apr 3:vkaf033. doi: 10.1093/jimmun/vkaf033. Epub ahead[...]